Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Pancaran Samudera Transport Tbk. (PSAT) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Pancaran Samudera Transport Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Pancaran Samudera Transport Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Pancaran Samudera Transport Tbk. trades at Rp890 (market cap 1.31T, 179.6K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 9.6× Pancaran Samudera Transport Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (235.2K versus 179.6K). Which is the better fit depends on your goals.

PSATTSPC
Market Cap
1.31T12.58T
Volume
179.6K235.2K
Lot
1.8K2.35K
Turnover
157.1M649.94M
Average Price
874.732,763.37
Value
157.1M649.94M
Indicative Equilibrium Price
8902,780
Indicative Equilibrium Volume
29

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

PSAT
View details
TSPC
View details

About Pancaran Samudera Transport Tbk.

PT Pancaran Samudera Transport Tbk (the Company) was established on December 10, 2007 in the Republic of Indonesia based on the Notarial Deed No. 1 from Mary Maria, S.H, Notary in Depok. The Company commenced its operations in 2007. The Companys immediate parent company is PT Profitama Hasil Indah, incorporated and domiciled in Indonesia and its ultimate parent company is PT Pancaran Harapan Integra, also incorporated and domiciled in Indonesia.

Read more on PSAT

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC